{
  "abstract": "Jordt et al have recently documented an unregulated constituent, the nicotine analogue 6-methyl nicotine (6MN), in a range of products, including nicotine analogue pouch brands MG and Hippotine.1–4",
  "authors": [
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Lauren Czaplicki"
    },
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Meghan B Moran"
    },
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Ryan David Kennedy"
    },
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Dana Tfayli"
    },
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Suzanne Frisbee"
    },
    {
      "affiliations": [
        "Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Maryam Ibrahim"
    },
    {
      "affiliations": [
        "Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"
      ],
      "name": "Tory R Spindle"
    }
  ],
  "title": "Nicotine analogue pouches: a growing regulatory challenge",
  "uid": "ecd6844a-9a6f-5caf-b743-e365f5c0e194"
}